Virtu Financial LLC Axcella Health Inc. Transaction History

Virtu Financial LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 27, 2023	SELL	$0.22 - $0.46 $8,522 - $17,820	-38,740 Reduced 46.42%	44,716 $10,000
Q1 2023 May 01, 2023	BUY	$0.31 - $0.77 $25,871 - $64,261	83,456 New	83,456 $40,000
Q1 2022 May 17, 2022	SELL	$1.58 - $2.82 $35,478 - $63,323	-22,455 Closed	0 $0
Q4 2021 Feb 17, 2022	BUY	$2.06 - $3.61 $46,257 - $81,062	22,455 New	22,455 $47,000
Q1 2021 May 19, 2021	SELL	$4.55 - $6.72 $71,353 - $105,383	-15,682 Closed	0 $0
Q4 2020 Feb 24, 2021	BUY	$4.24 - $5.97 $66,491 - $93,621	15,682 New	15,682 $81,000
Q3 2020 Dec 11, 2020	SELL	$4.12 - $5.91 $89,762 - $128,761	-21,787 Closed	0 $0
Q2 2020 Aug 07, 2020	BUY	$2.94 - $7.7 $64,053 - $167,759	21,787 New	21,787 $120,000

61.6K

Ticker AXLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,500,896
Description
Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrenc...

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Virtu Financial LLC with notifications on news.